Topic: Health Care
A Psychological Approach to Helping Doctors Do Better at Doing No Harm
Behavioral nudges reduced doctors’ overprescribing and overtesting of older patients
Should the U.S. Aim for a Zero-COVID-19 Policy?
Tolerating a low level of transmission just might be the better strategy
$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents
The figure is a subset, not covering huge expense of extended patents on high-priced biologics like Humira
Anticipating Overcrowding Risk in the ICU
A model vastly outperforms predictions based on prior hospital data
Nursing Home Industry Profits Obscured by Related-Party Transactions
Management and real estate deals to owners’ firms siphon off most profits
The Case for Field Experiments in Behavioral Research
Nudges already proven to work in the real-world increased uptake of COVID-19 boosters; nudges based on lab findings and expert insights, not so much
A Supportive Letter to Doctors on Best Practices Reduces Opioid Prescriptions
In LA, doctors who lose a patient to opioid overdose get a letter from the coroner; tweaking that letter had a substantial impact
When Medicare Pays, Drug Companies Employ Older Subjects in Clinical Trials
The shift lends credibility to medicines vs. trials that exclude people 65 and older
Was Research — on Physicians and Noncompete Agreements — Before Its Time?
Years after a paper goes unpublished, it’s fodder for a major Federal Trade Commission proposal
Huge Spending — But Little Sharing of Research Results — on Cancer Drugs
U.S. efforts to encourage transparency widely ignored by companies
A Nudge to Reduce the Government Tab for Nursing Home Care
An upfront fee for taking Medicaid patients could shorten stays
‘They Were Already Inside My Head To Begin With’
The ethics of asking brain surgery patients to allow unrelated research while on the operating table
Dividing Patients Between Telehealth, In-Office Primary Care and Referral to Specialists
Getting the mix right is the goal of a Medicare pilot, which itself could use substantial improvement
Modest Financial Incentives Help with Weight Loss
Tying payments to weight, rather than behaviors, marginally more effective
FDA’s Breakthrough Program: Faster Drug OKs Without Sacrificing Safety
Dedicated FDA staff guide companies during design of clinical trials
Mandated Disclosure of Clinical Trials Ignored — Especially for Competitive Drugs
Pharma companies less likely to disclose critical drug information than public institutions